Dean Capital Investments Management LLC Has $3.35 Million Position in Evolent Health Inc (NYSE:EVH)

Share on StockTwits

Dean Capital Investments Management LLC lifted its position in Evolent Health Inc (NYSE:EVH) by 156.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 465,717 shares of the technology company’s stock after acquiring an additional 284,119 shares during the quarter. Evolent Health makes up approximately 1.9% of Dean Capital Investments Management LLC’s portfolio, making the stock its 4th largest position. Dean Capital Investments Management LLC’s holdings in Evolent Health were worth $3,349,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Aperio Group LLC bought a new stake in shares of Evolent Health during the second quarter valued at about $40,000. ETRADE Capital Management LLC bought a new stake in shares of Evolent Health during the second quarter valued at about $80,000. DekaBank Deutsche Girozentrale increased its position in shares of Evolent Health by 94.4% during the second quarter. DekaBank Deutsche Girozentrale now owns 12,061 shares of the technology company’s stock valued at $95,000 after buying an additional 5,856 shares during the period. GABELLI & Co INVESTMENT ADVISERS INC. increased its position in shares of Evolent Health by 38.4% during the second quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 15,500 shares of the technology company’s stock valued at $123,000 after buying an additional 4,300 shares during the period. Finally, NumerixS Investment Technologies Inc bought a new stake in shares of Evolent Health during the second quarter valued at about $125,000. Hedge funds and other institutional investors own 98.41% of the company’s stock.

Several equities research analysts have recently weighed in on the company. Oppenheimer set a $15.00 price target on Evolent Health and gave the company a “buy” rating in a research report on Wednesday, August 7th. Cantor Fitzgerald set a $16.00 price objective on shares of Evolent Health and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Cowen set a $18.00 price objective on shares of Evolent Health and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Piper Jaffray Companies upped their price objective on shares of Evolent Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Finally, ValuEngine upgraded shares of Evolent Health from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $15.75.

In related news, Director Kenneth A. Samet acquired 7,200 shares of the company’s stock in a transaction dated Thursday, August 15th. The stock was purchased at an average price of $7.04 per share, with a total value of $50,688.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Doug S. Aron acquired 10,550 shares of the company’s stock in a transaction dated Wednesday, August 14th. The shares were bought at an average cost of $8.20 per share, with a total value of $86,510.00. 4.50% of the stock is owned by company insiders.

NYSE EVH traded up $0.11 on Tuesday, reaching $9.38. 5,818 shares of the company’s stock traded hands, compared to its average volume of 1,064,698. Evolent Health Inc has a 12 month low of $5.50 and a 12 month high of $26.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.19 and a quick ratio of 1.19. The stock has a 50-day simple moving average of $7.69 and a 200 day simple moving average of $8.76. The stock has a market cap of $782.66 million, a PE ratio of -26.89 and a beta of 1.07.

Evolent Health (NYSE:EVH) last issued its quarterly earnings results on Tuesday, November 5th. The technology company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.03. Evolent Health had a negative net margin of 15.02% and a negative return on equity of 6.93%. The business had revenue of $220.14 million for the quarter, compared to analysts’ expectations of $217.90 million. During the same period last year, the business earned ($0.04) earnings per share. The business’s quarterly revenue was up 46.8% on a year-over-year basis. As a group, analysts anticipate that Evolent Health Inc will post -0.95 EPS for the current year.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Featured Story: Book Value Per Share – BVPS

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.